The global cell expansion market accounted for a value of USD 11.9 billion in 2019 and is projected to register growth at a CAGR of 13.3% during forecast period.
COVID-19 has impacted the cell expansion market. The cell based approaches which uses mesenchymal stromal cells (MSCs) provides an approach to migrate the adverse effects of corona virus infection. This therapy helps in reducing the expression of pro-inflammatory cytokines and helps in repairing the damaged tissues in COVID-19 patients. The market for cell expansion is growing rapidly as stem cell based therapies is significantly utilized in COVID-19 study. In COVID-19 research, various cell expansion products and instruments are used. The outbreak of cell expansion has positive impact on cell expansion market.
For more details, visit: Global Cell Expansion Market By Cell Type (Animal Cell and Human Cell), By Product (Consumables, Instruments, Others), By End-Users (Cell Banks, Research Institutes, Others), By Application, By Region, Forecast & Opportunities to 2026
Cell expansion is used in research and development department in healthcare industry for treatment of diseases. It is also used to produce therapeutics, vaccines, antibiotics and drugs. The incidence of various diseases such as cancer and diabetes are increasing, which needs extensive research in order to develop new treatment options. This drives growth in cell expansion market during forecast period.
On the basis of product, the cell expansion market is segmented into consumables, instruments, automated cell expansion system and bioreactors. The consumables segment accounted for largest market share of 46.8% in 2019 and it is estimated to dominate the market during forecast period. The production of vaccines is increasing in the world. The biopharmaceutical and biotechnology industries are widely adopting various biologics. Wide range of reagents product are available which are dedicated to specific type of cell. The consumables products are ready-to-use and convenient. The use of consumables is increasing around the world and this drives growth in consumables segment during forecast period.
On the basis of cell type, the cell expansion market is segmented into animal cell and human cell. The human cell segment accounted for the largest market share in the 2019 and it is estimated to maintain its dominance over forecast period. The human cells segment includes differentiated cells and stem cells. The investment in human cells segment for research is increasing by private and public organizations. The application of human cells particularly stem cells is increasing around the world. The incidence of various diseases such as cancer is increasing among humans which increases demand for human cell expansion segment and drives growth in human cell segment during forecast period.
On the basis of product, the cell expansion market is segmented into regenerative medicine & stem cell research, cancer & cell based research and others. The medicine & stem cell research segment is estimated to dominate the market during forecast period. The funding for medicine & stem cell research is increasing around the globe and the growth in this application is increasing. Thus, drives growth in medicine & stem cell research segment during forecast period.
North America region accounted for largest market share in 2019. The incidence of various diseases such as cancer etc is increasing around the world and this requires extensive research and the funding is also increasing in this region for cell therapies. However, the Asia-Pacific region is estimated to witness fastest growth during forecast period. Several biotechnological and pharmaceuticals companies are putting their efforts to commercialize their cellular therapies in this region. Various companies in have signed an alliance in order to commercialize the cell based products in this region. Thus, drives growth in Asia-Pacific region during forecast period.
The key market players in cell expansion industry are Thermo Fisher Scientific Inc., Danaher, Becton, Dickinson and Company, Lonza, Corning Incorporated, Merck KGAA, Sartorius Stedim Biotech, Getinge AB, Terumo Corporation, Miltenyi Biotec, Stemcell Technologies Inc., Solida Biotech GMBH, Cellexus, Eppendorf AG, Himedia Laboratories and Kohjin Bio.
- What are the expected industry trends over the next three to five years?
- Which of the cell expansion type is likely to lead by 2025?
- Which of the end-user segments is expected to have the maximum potential to during the forecast period?
- Which region is going to have the highest smart meters market share by 2025?
- What are different organic and inorganic strategies implemented by companies to gain increased market share?